Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder

ClinicalTrials.gov ID: NCT01506154

Public ClinicalTrials.gov record NCT01506154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 8:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Topical Patch in the Treatment of Pain Due to Recent Onset Supraspinatous and/or Subacromial Tendonitis/Bursitis and/or Subdeltoid Bursitis of Shoulder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Pain due to Recent Onset Supraspinatous and/or Subacromial Tendonitis/Bursitis and/or Subdeltoid Bursitis of the Shoulder.

Study identification

NCT ID
NCT01506154
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
MEDRx USA, Inc.
Industry
Enrollment
210 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
14 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2011
Primary completion
Sep 30, 2012
Completion
Sep 30, 2012
Last update posted
Jan 15, 2018

2011 – 2012

United States locations

U.S. sites
27
U.S. states
16
U.S. cities
26
Facility City State ZIP Site status
Not listed Birmingham Alabama 35216
Not listed Scottsdale Arizona 85258
Not listed Los Angeles California 90036
Not listed San Diego California 92120
Not listed Denver Colorado 80239
Not listed Clearwater Florida 33761
Not listed Coral Gables Florida 33134
Not listed Fort Lauderdale Florida 33136
Not listed Kissimmee Florida 34741
Not listed Lauderdale Lakes Florida 33319
Not listed Miami Florida 33155
Not listed Orlando Florida 32804
Not listed Boise Idaho 83702
Not listed Lexington Kentucky 40504
Not listed Marrero Louisiana 70072
Not listed Southfield Michigan 48034
Not listed Raleigh North Carolina 27612
Not listed Fargo North Dakota 58103
Not listed Zanesville Ohio 43701
Not listed Gresham Oregon 97030
Not listed Altoona Pennsylvania 16602
Not listed Charleston South Carolina 29412
Not listed Dallas Texas 75254
Not listed El Paso Texas 79902
Not listed San Antonio Texas 78207
Not listed San Antonio Texas 78229
Not listed Temple Texas 76502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01506154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 15, 2018 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01506154 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →